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INTRODUCTION
Robot-assisted laparoscopic radical prostatectomy (RALRP) is
commonly performed in the surgical treatment of prostate cancer.
Its advantages over conventional surgery include nerve sparing,
shorter hospitalization times, reduced blood loss, and reduced
postoperative pain (1). However, to maximize the surgical visual
field during this procedure, patients need to be placed in steep
Trendelenburg position (25or more), which can sometimes cause
hemodynamic changes (2, 3). Indeed, a retrospective study re-
vealed frequent use of vasoactive drugs to treat hypotension and
hypertension during this procedure (4). Thus, an invasive radial
arterial line is routinely inserted to monitor hemodynamic changes
during RALRP.
It is possible, however, for blood pressure to be measured con-
tinuously and noninvasively with systems based on the volume
clamp method. For example, the ClearSight system (previously
known as Nexfin ; BMEYE, Amsterdam, The Netherlands) en-
ables a totally noninvasive continuous blood pressure and cardiac
output monitoring based on finger arterial pressure pulse contour
analysis. Specifically, the system reconstructs finger arterial pres-
sure waveforms into brachial artery pressure waveforms using a
generalized algorithm (5, 6). Its potential advantages include being
noninvasive and easy to use, and multiple studies have already
investigated its accuracy in comparison to invasive monitoring
methods, with varying results (5, 7 -11).
Until recently, RALRP has been considered suitable for patients
with American Society of Anesthesiologists (ASA) physical status I -
II. However, this minimally invasive operation is performed in pa-
tients with ASA physical statusbecause of its fewer periopera-
tive complications. Since steep Trendelenburg position and pneu-
moperitoneum can contribute to circulatory deterioration in pa-
tients who have cardiac or other diseases, we need more informa-
tion from a continuous monitor during the operation. The pur-
pose of this study was therefore to investigate whether noninvasive
continuous arterial blood pressure measurements using the
ClearSight system were comparable to those obtained invasively in
patients undergoing RALRP.
PATIENTS AND METHODS
After receiving approval from the hospital ethics committee, 10
patients scheduled for RALRP with ASA physical status classifica-
tions of I - II were included in this study. All patients provided written
informed consent.
Anesthetic procedure and intraoperative monitoring
No premedication was given. Anesthesia was induced with pro-
pofol (1.0 -1.5 mg/kg intravenously [i.v.]) and remifentanil (0.3 -0.5
µg/kg/min i.v.). Tracheal intubation was facilitated by the admini-
stration of rocuronium (0.5 mg/kg i.v.). Anesthesia was main-
tained with desflurane (4.0%-5.0%) and remifentanil (0.1 -0.3 µg/kg/
min i.v.). Rocuronium was repeated as needed for muscle relaxa-
tion.
After the induction of general anesthesia, a radial arterial can-
nula with a 22-gauge catheter was inserted into the left radial
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artery for blood sampling and pressure monitoring. A sensor/
transducer system (FloTrac ; Edwards Lifesciences Co., Irvine,
CA, USA) was connected to the radial artery catheter to measure
the arterial waveform. Intraoperative monitoring also included
continuous electrocardiography as well as continuous heart rate,
mean arterial pressure (MAP), peripheral capillary oxygen satura-
tion, end-tidal carbon dioxide, and naso-nasal temperature meas-
urements. For noninvasive blood pressure monitoring, the ClearSight
device was placed on the middle finger of the right hand accord-
ing to the manufacturer’s recommendation, and its heart reference
system (HRS) was zeroed at the level of the patient’s midaxillary
line. Pneumoperitoneum was then created by insufflation of carbon
dioxide and five transabdominal ports were placed ; after which,
the patients were moved from the lithotomy to the Trendelenburg
position with a 25head-down tilt. Each time the patient’s position
was changed, the HRS and the arterial system were recalibrated.
At seven defined time points, systolic, diastolic, and mean arte-
rial blood pressure were read out from both the FloTrac (invasive
monitoring) and the ClearSight (noninvasive monitoring) devices.
These time points were as follows : (1) 5 min after the start of the
operation ; (2) 5 min after the creation of pneumoperitoneum with
carbon dioxide ; (3) 15, (4) 30, and (5) 60 min after the patients
were placed in the head-down position ; (6) immediately after
pneumoperitoneum was stopped and patients were returned to the
horizontal lithotomy position ; and (7) immediately after the opera-
tion. Invasive and noninvasive blood pressure measurement pairs
at each of these seven time points were documented and com-
pared in each patient.
Statistics
Agreement between invasive and noninvasive blood pressure
measurements was assessed using the Bland-Altman method
(12). Spearman correlation coefficients (ρ) were calculated after
normality was checked and corrected for repeated measurements.
Bland-Altman analysis was then carried out to reveal the bias
(difference between invasive and noninvasive arterial pressure
values), precision (standard deviation, or SD), and 95% limits of
agreement (bias2SD) between the two measurement methods.
Statistical analyses were carried out using the SPSS statistical soft-
ware (IBM, New York, NY, USA).
RESULTS
Ten patients with ASA physical status I -II, from which a total of
210 blood pressure measurement pairs were collected, were in-
cluded in this study. Patient characteristics are summarized in
Table 1.
Bland-Altman analysis for FloTrac and ClearSlight systolic arte-
rial pressure (SAP) measurements revealed a mean bias and preci-
sion of -2.9915.8 mmHg and upper and lower LoAs of 28.06 and -
34.04 mmHg, respectively. Additionally, the Spearman correlation
coefficient was ρ= 0.662 (P0.001) (Figure 1).
Bland-Altman analysis for FloTrac and ClearSight diastolic arte-
rial pressure (DAP) measurements revealed a mean bias and
precision of -12.03 mmHg10.84 mmHg, and upper and lower
LoAs of 9.21 mmHg and -33.27 mmHg, respectively. The Spearman
correlation coefficient was ρ= 0.521 (P0.001) (Figure 2).
Finally, Bland-Altman analysis for FloTrac and ClearSight MAP
measurements revealed a mean bias and precision of -9.26 mmHg
11.61 mmHg and upper and lower LoAs of 13.50 and -32.02 mmHg,
respectively. The Spearman correlation coefficient was ρ = 0.625
(P0.001) (Figure 3).
DISCUSSION
The blood pressure obtained by the ClearSight system in this
study does not meet the criteria applied to the currently used inva-
sive monitoring system, but it correlated well with that measured
invasively during RALRP. Specifically, all bias values for SAP, DAP,
and MAP were negative (i.e., the device tended to overestimate
blood pressure). Although the bias for SAP measurements was
very low, the SD was still too high (i.e., the precision too low) to be
clinically acceptable.
In the absence of validation criteria for continuous blood pres-
sure monitoring systems, the Association for the Advancement of
Medical Instrumentation criteria regarding intermittent noninva-
sive blood pressure monitoring devices is usually used (13). Ac-
cording to these criteria, two techniques can only be used inter-
changeably if the bias (in our case, the difference between ClearSight
and FloTrac measurements) is less than 5 mmHg with an SD of less
than 8 mmHg (14). A review by Ameloot et al. (6) on the accu-
racy of the finger cuff method in measuring blood pressure
found that most authors reported a small bias (weighted aver-
age of 2 mmHg) with an almost acceptable SD (weighted aver-
age of 9 mmHg). Conflicting results within the literature were
explained by differences in study populations and, in some cases,
application of the method in patients with reduced perfusion of the
hand due to severe hypotension, high peripheral resistance, ad-
ministration of high-dose vasopressors, hypothermia, or periph-
eral edema (10). By contrast, Kim et al. (11) reviewed 28 studies
comparing noninvasive arterial pressure monitoring with invasive
arterial pressure, and they described that bias, as reported in
method comparison studies using Bland-Altman analysis, would
result in a greater mean error and SD than these standards recom-
mend.
In this study, the differences between all bias values for SAP,
DAP, and MAP were negative, that it, the device tended to overesti-
mate blood pressure. It is widely known that systemic pressure
increases as the measurement location is moved toward the periph-
ery of the body and away from the heart, and with the ClearSight
system predicting brachial artery pressure, the blood pressure
should be lower than of the radial artery. These results were ob-
tained despite the recalibration of the HRS and the radial artery
pressure whenever the patient’s position was changed. Therefore,
we assume the possibility that the zero position might be displaced
after placing the patient in steep Trendelenburg position.
Despite these conflicting results, such monitoring would be ad-
vantageous in RALRP. Although the procedure has postoperative
benefits such as shorter hospitalization times, reduced blood loss,
and reduced postoperative pain, intraoperativemanagement is
Table1 : Patient characteristics.
N=10
Age (years), mean (SD), range 65(6.3),53 -73
Height (cm), mean (SD), range 166.1(8.0),152 -177
Weight (kg), mean (SD), range 65.5(11.5),46 -84
BMI (kg/m2), mean (SD) 23.4(3.6)
ASA physical status I/II 4/6
Comorbidities
Hypertension 5
Diabetes 3
CABG placement 1
Cerebral infarction 1
ASA, American Society of Anesthesiologists ; BMI, body mass index ;
CABG, coronary artery bypass graft ; SD, standard deviation.
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Figure 1. Bland-Altman plot for systolic blood pressure measurements. Dot, mean of the FloTrac (invasive) and ClearSight (noninvasive) blood
pressure measurements at one time point in one patient ; continuous line, mean difference (bias) between the two measurement methods ; striped
lines, 95% limits of agreement (bias2 × standard deviation).
Figure 2. Bland-Altman plot for diastolic blood pressure measurements. Dot, mean of the FloTrac (invasive) and ClearSight (noninvasive) blood
pressure measurements at one time point in one patient ; continuous line, mean difference (bias) between the two measurement methods ; striped
lines, 95% limits of agreement (bias2 × standard deviation).
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more complex. Namely, hemodynamic variables are affected by
carbon dioxide pneumoperitoneum and the steep Trendelenburg
position. This causes marked increases in MAP, central venous
pressure, and pulmonary capillary wedge pressure as well as
marked decreases in cardiac output and stroke volume (3, 14).
Blood pressure monitoring with an intra-arterial catheter is there-
fore routinely used during RALRP because it provides continuous
arterial pressure measurements and allows for blood sampling.
However, continuous monitoring can cause cannulation-related
side effects. Furthermore, intra-arterial pressure monitoring is not
needed after RALRP because of its minimal invasiveness.
We therefore hypothesized that, in this context, the noninvasive
ClearSight system could be used as an alternative to invasive arte-
rial monitoring. However, based on our findings, noninvasive
blood pressure measurements using the ClearSight system were
not comparable to those obtained invasively. In this study, we only
investigated blood pressure. The ClearSight system provides
other hemodynamic parameters such as cardiac output, cardiac
index, and stroke volume. We can control the depth of anesthesia,
infusion rate, and use of vasoactive agents based on rapid changes of
these parameters. Although the difference in the blood pressure
values obtained was large, the ClearSight system seems to have the
obvious advantage for monitoring.
Despite the insights provided by our study, it does have some
limitations. First, the number of patients was too low to conclu-
sively account for the low correlation between the two monitoring
methods. Second, we chose only seven time points during the op-
eration while taking into account different conditions, such as pos-
ture and pneumoperitoneum, that might have affected the accu-
racy of our measurements. More studies are required in other pa-
tient groups to determine the clinical usefulness of the ClearSight
system.
In conclusion, although the ClearSight system is a safe and con-
venient tool, further studies on hemodynamic changes during
RALRP are needed to clarify the benefit from this noninvasive
technique.
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